American Chemical Society
Browse
jm9704816_si_001.pdf (464.45 kB)

Ethnobotanical-Directed Discovery of the Antihyperglycemic Properties of Cryptolepine: Its Isolation from Cryptolepis sanguinolenta, Synthesis, and in Vitro and in Vivo Activities

Download (464.45 kB)
journal contribution
posted on 1998-02-24, 00:00 authored by Donald E. Bierer, Diana M. Fort, Christopher D. Mendez, Jian Luo, Patricia A. Imbach, Larisa G. Dubenko, Shivanand D. Jolad, R. Eric Gerber, Joane Litvak, Qing Lu, Pingsheng Zhang, Michael J. Reed, Nancy Waldeck, Reimar C. Bruening, Ben K. Noamesi, Richard F. Hector, Thomas J. Carlson, Steven R. King
Using an ethnobotanical approach in combination with in vivo-guided fractionation as a means for lead discovery, cryptolepine was isolated as an antihyperglycemic component of Cryptolepis sanguinolenta. Two syntheses of cryptolepine, including an unambiguous synthesis, are reported. The hydroiodide, hydrochloride, and hydrotrifluoromethanesulfonate (hydrotriflate) salts of cryptolepine were synthesized, and a comparison of their spectral properties and their in vitro activities in a 3T3-L1 glucose transport assay is made. Cryptolepine and its salt forms lower blood glucose in rodent models of type II diabetes. While a number of bioactivities have been reported for cryptolepine, this is the first report that cryptolepine posesses antihyperglycemic properties.

History